# CCB International

> CCB International is a VC fund backing Health Care and Biotechnology. See 79 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Central, Hong Kong
- Total investments: 79
- Last investment: Apr 2026
- Lead investor: 35%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ccb-international-capital-limited/
- Website: http://www.ccbintl.com.hk/

CCB International is a VC fund in Central focused on Health Care and Biotechnology. CCB International (Holdings) Limited and its subsidiaries (CCB International) is an investment services flagship which is owned by China Construction Bank Corporation ("CCB"). Its core business is divided into three main areas, namely Pre-IPO, IPO and Post-IPO which in turn form a comprehensive investment services value chain that offersa full range of products, and services including sponsoring and underwriting, financial advisory, corporate mergers and acquisitions and restructuring, additional issuance and placement of shares and refinancing forlisted companies, direct investment, asset management, securities brokerage, market research, investment consultancy, etc.

## Contacts

5 contacts available for CCB International. Shizune tracks 3 team members at CCB International. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ccb-international?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.5M–$313M |
| Series B | $2.8M–$1.6B |
| Series C | $44M–$150M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 17 | 22% |
| Biotechnology | 14 | 18% |
| Manufacturing | 10 | 13% |
| Medical | 8 | 10% |
| Artificial Intelligence | 8 | 10% |

101 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 16 | 20% |
| Series A | 15 | 19% |
| Series B | 14 | 18% |
| Funding Round | 8 | 10% |
| Series D | 7 | 9% |

15 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 61 | 77% |
| United States | 3 | 4% |
| Hong Kong | 2 | 3% |
| Singapore | 2 | 3% |
| United Kingdom | 2 | 3% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Richard Cheng | Head of Business Development | 0 | https://shizune.co/investors/profile/richard-cheng |
| Rong Yue | Head of Investment Services | 0 | https://shizune.co/investors/profile/rong-yue |
| Hu Zhanghong Hu Zhanghong | CEO | 0 | https://shizune.co/investors/profile/hu-zhanghong-hu-zhanghong |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Astrall | Astrall is a robotics platform company founded by Odie, the former head of DJI’s core Inspire series, leveraging deep expertise in advanced drone systems and robotics engineering to build next-generation robotic platforms that push the boundaries of performance, reliability, and intelligent automation. |  | Seed | Apr 09, 2026 |  |
| Huaxuan Sensing | Huaxuan Sensing is a sensor technology company that focuses on the development of resolver sensors for the new energy automobile industry. |  | Venture - Series Unknown | Jan 15, 2026 |  |
| Lunar Exploration Power | Lunar Exploration Power is a technology company specializing in the research, development, and manufacturing of intelligent robotic systems. The company is committed to advancing the field of robotics through innovation in artificial intelligence, automation, and precision engineering, providing cutting-edge robotic solutions for applications inindustrial, scientific, and exploration environments. |  | Angel | Nov 05, 2025 |  |
| Fanzhi Medicine | Fanzhi Medicine provides instruments, chips, diagnostic reagents, Internet remote diagnosis and treatment products, and services, encourages advanced nucleic acid diagnostic technology to enter the primary medical system, benefits the general public, and establishes an internationally advanced brand of rapid diagnosis and treatment of majordiseases. |  | Series D | Aug 21, 2025 |  |
| Xinqiang Technology | Xinqiang Technology is a digital full-stack solution provider specializing in integrated solutions that combine hardware, software, cloud services, and artificial intelligence (AI) tailored for traditional industries. | $1.4M | Series A | Mar 28, 2025 |  |
| Syngenta Group | Syngenta Group is an agriculture innovation companies, with roots going back more than 250 years. Its 48,000 people across more than 100 countries strive to transform agriculture through breakthrough products and technologies that play a vital role in enabling the food chain to feed the world safely, sustainably and with respect for our planet.Swiss headquartered and Chinese-owned, the Group draws strength from its four business units – Syngenta Crop Protection headquartered in Switzerland, Syngenta Seeds headquartered in the United States, ADAMA headquartered in Israel, and Syngenta Group China – that provide industry-leading ways to serve customers everywhere. | $4.5B | Debt Financing | Dec 24, 2024 |  |
| Galaxy Bot | Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products. | $69.1M | Venture - Series Unknown | Nov 18, 2024 |  |
| SINOGENE | Sinogene uses a solution called somatic cell nuclear transfer for pet cloning. Sinogene believes that the advancement of breeding and genetics will be beneficial to animal genetic research. The company's team includes scientists, doctors, and veterinary specialists. | $7M | Series C | Sep 19, 2024 |  |
| Hangzhou Times Electric Technology | Times Electric is a developer of new energy vehicles and core components. |  | Series A | Mar 14, 2023 |  |
| Thor Innovation | Thor Innovation is a high-tech enterprise mainly engaged in haptics, an electronic simulation of tactile sense. | $12.9M | Series A | Feb 24, 2023 |  |

10 of 79 investments shown.

## Co-investors
- [Shenzhen Capital Group](https://shizune.co/investors/profile/shenzhen-capital-group) — VC Fund, 7 deals together
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 5 deals together
- [Tencent](https://shizune.co/investors/profile/tencent) — VC Fund, 5 deals together
- [Green Pine Capital Partners](https://shizune.co/investors/profile/green-pine-capital-partners) — VC Fund, 4 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 4 deals together
- [Beijing E-town International Investment & Development](https://shizune.co/investors/profile/beiid) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)
- [Hospitality Investors in China](https://shizune.co/investors/hospitality-investors-china)
- [Hospitality VC Funds in China](https://shizune.co/investors/hospitality-vc-funds-china)
- [Sports VC Funds in China](https://shizune.co/investors/sports-vc-funds-china)

## FAQ

### What does CCB International invest in?

CCB International invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series C and Series A stage. Most of the 79 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is CCB International's check size?

CCB International typically joins rounds of $1.5M–$313M at Series A, $2.8M–$1.6B at Series B and $44M–$150M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CCB International participates in.

### How do I contact CCB International?

Public channels for CCB International include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at CCB International?

The team at CCB International includes Richard Cheng (Head of Business Development), Rong Yue (Head of Investment Services) and Hu Zhanghong Hu Zhanghong (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co